Sanofi Research and Development Expenses 2010-2024 | SNY
Sanofi annual/quarterly research and development expenses history and growth rate from 2010 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
- Sanofi research and development expenses for the quarter ending December 31, 2024 were $2.263B, a 12.23% increase year-over-year.
- Sanofi research and development expenses for the twelve months ending December 31, 2024 were $8.001B, a 9.88% increase year-over-year.
- Sanofi annual research and development expenses for 2024 were $8.001B, a 9.88% increase from 2023.
- Sanofi annual research and development expenses for 2023 were $7.282B, a 3.06% increase from 2022.
- Sanofi annual research and development expenses for 2022 were $7.065B, a 4.92% increase from 2021.
| Sanofi Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2024 | $8,001 |
| 2023 | $7,282 |
| 2022 | $7,065 |
| 2021 | $6,734 |
| 2020 | $6,316 |
| 2019 | $6,740 |
| 2018 | $6,961 |
| 2017 | $6,185 |
| 2016 | $5,723 |
| 2015 | $5,643 |
| 2014 | $6,413 |
| 2013 | $6,336 |
| 2012 | $6,330 |
| 2011 | $6,701 |
| 2010 | $5,844 |
| 2009 | $6,391 |
| Sanofi Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2024-12-31 | $2,263 |
| 2024-09-30 | $2,036 |
| 2024-06-30 | $1,835 |
| 2024-03-31 | $1,866 |
| 2023-12-31 | $2,017 |
| 2023-09-30 | $1,810 |
| 2023-06-30 | $1,777 |
| 2023-03-31 | $1,678 |
| 2022-12-31 | $1,882 |
| 2022-09-30 | $1,748 |
| 2022-06-30 | $1,764 |
| 2022-03-31 | $1,671 |
| 2021-09-30 | $1,702 |
| 2021-06-30 | |